PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Asthma drug prevents spread of breast cancer: study

2010-11-04
(Press-News.org) TORONTO, Ont. — November 1, 2010 — A drug commonly used in Japan and Korea to treat asthma has been found to stop the spread of breast cancer cells traditionally resistant to chemotherapy, according to a new study led by St. Michael's pathologist Dr. Gerald Prud'homme.

"Tranilast, a drug approved for use in Japan and South Korea, and not in use in Canada or the U.S., has been used for more than two decades to treat asthma and other allergic disorders including allergic rhinitis and atopic dermatitis," Dr. Prud'homme says. "Now, our study is the first to discover it not only stops breast cancer from spreading but how the drug targets breast cancer cells."

Researchers grew breast cancer stem cells, which give rise to other cancer cells, in culture. The cells were injected into two groups of mice, including one group, which was also treated with tranilast. Dr. Prud'homme and his colleagues found the drug reduced growth of the primary cancerous tumour by 50 per cent and prevented the spread of the cancer to the lungs. Researchers also identified a molecule in the cancer cell that binds to tranilast and appears to be responsible for this anti-cancer effect.

Tranilast binds to a molecule known as the aryl hydrocarbon receptor (AHR), which regulates cell growth and some aspects of immunity. This makes the drug beneficial in treating allergies, inflammatory diseases and cancer.

"For the first time, we were able to show that tranilast shows promise for breast cancer treatment in levels commonly well-tolerated by patients who use the drug for other medical conditions," Dr. Prud'homme said. "These results are very encouraging and we are expanding our studies. Further studies are necessary to determine if the drug is effective against different types of breast and other cancers, and its interaction with anti-cancer drugs.

### Dr. Prud'homme says clinical trials in cancer patients may be possible within a few years. The study is published today in the journal PLoS ONE.

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who walk through its doors. The Hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, and care of the homeless are among the Hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing Knowledge Institute, research at St. Michael's Hospital is recognized and put into practice around the world. Founded in 1892, the Hospital is fully affiliated with the University of Toronto.

END



ELSE PRESS RELEASES FROM THIS DATE:

Simple blood test may diagnose deadly Niemann-Pick type C disease

2010-11-04
VIDEO: Niemann-Pick type C, a fatal genetic disorder that frequently takes years to diagnose, may now be detectable with a simple blood test, according to researchers at Washington University School of... Click here for more information. A fatal genetic disorder that frequently takes years to diagnose may soon be detectable with a simple blood test, researchers at Washington University School of Medicine in St. Louis and the National Institutes of Health (NIH) report this week ...

Study shows volunteering benefits those with functional limitations

2010-11-04
TEMPE, Ariz. – Volunteering is known to provide health benefits to the person doing the volunteering. Now, a new study finds that older adults with functional limitations (trouble conducting daily tasks like cooking meals) in particular appear to reap the benefits from helping others. The new study addresses the question of whether the impact of volunteering on risk of mortality was stronger for older adults with or without functional limitations. "As functional limitations increase, the risk of dying increases, but not among those who volunteered," said Morris Okun, ...

Neutron stars may be too weak to power some gamma-ray bursts

Neutron stars may be too weak to power some gamma-ray bursts
2010-11-04
A gamma-ray burst is an immensely powerful blast of high-energy light thought to be generated by a collapsing star in a distant galaxy, but what this collapse leaves behind has been a matter of debate. A new analysis of four extremely bright bursts observed by NASA's Fermi satellite suggests that the remnant from a long-duration gamma-ray burst is most likely a black hole – not a rapidly spinning, highly magnetized neutron star, or magnetar since such a burst emits more energy than is theoretically possible from a magnetar. "Some of the events we have been finding ...

New research identifies the plight of farmland birds

2010-11-04
Farmland birds that are poorer parents and less "brainy" are faring worse than other farmland bird species, a study at the University of Bristol has found. The new research, published today in Proceedings of the Royal Society B, found that farmland birds are undergoing dramatic decline across the world, but some bird species are suffering more than others. Unexpectedly, the study also found that medium-sized birds, for example, starlings and skylarks in Europe, rather than large birds were found to suffer more in farmland, unlike studies of other animals in other ...

Plants and animals under stress may provide the key to better stock market predictions

2010-11-04
Stock markets react to crisis in a similar way to plants and the human body, according to a major new study that may help to predict future financial down-turns. An extensive analysis of biological and financial data suggests that systems under stress exhibit similar symptoms, whether they be polluted forests, cancer patients or the FTSE 100. There is an uncanny parallel between the way that humans, animals and plants adapt to harsh living conditions and the behaviour under stress of stock market prices and the banking sector, according to a report on the study by a ...

Stone Age humans needed more brain power to make big leap in tool design

2010-11-04
Stone Age humans were only able to develop relatively advanced tools after their brains evolved a greater capacity for complex thought, according to a new study that investigates why it took early humans almost two million years to move from razor-sharp stones to a hand-held stone axe. Researchers used computer modelling and tiny sensors embedded in gloves to assess the complex hand skills that early humans needed in order to make two types of tools during the Lower Palaeolithic period, which began around 2.5 million years ago. The cross-disciplinary team, involving researchers ...

Specific changes in the brain associated with sleep deprivation described in new study

2010-11-04
SEATTLE, Wash.—November 3, 2010—Researchers at the Allen Institute for Brain Science and SRI International have published the most systematic study to date of the effects of sleep deprivation on gene expression in the brain. The findings have implications for improving the understanding and management of the adverse effects of sleep deprivation on brain function. The study, available in Frontiers in Neuroscience, has created an extensive and detailed map of gene activity, known as gene expression, in the mouse brain across five behavioral conditions including sleeping, ...

Etanercept helps restore normal growth in children with juvenile arthritis

2010-11-04
Researchers from the Cincinnati Children's Hospital Medical Center observed a statistically significant increase in mean height, weight, and body mass index (BMI) percentiles in patients with juvenile idiopathic arthritis (JIA) who were treated with etanercept or etanercept plus methotrexate (MTX). JIA patients treated with MTX alone did not display an increase in growth percentiles. Results of the 3-year study are available online and in the November issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology. ...

Study finds bortezomib to be promising treatment for rheumatoid arthritis

2010-11-04
A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR). RA is ...

Honey bees: Genetic labeling decides about blue blood

2010-11-04
It is hard to believe that they belong to the same species: The large, long-lived queen bee is busy producing offspring throughout her lifetime. The much smaller worker bees, on the other hand, gather food, take care of the beehive, look after and feed the brood – but they are infertile. "The honey bee is an extreme example of different larval development," Professor Frank Lyko explains. Lyko, a scientist at DKFZ, studies how genes are regulated by chemical labeling with methyl groups. This type of regulation is part of what are called epigenetic regulation mechanisms ...

LAST 30 PRESS RELEASES:

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

Setting the stage for the “Frankfurt Alliance”

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] Asthma drug prevents spread of breast cancer: study